Inventor · disambiguated record
Rebecca Casaubon
Also filed as: CASAUBON REBECCA · CASAUBON REBECCA L
6 granted patents·11 pending applications·15 citations·filing 2007–2018
76Inventor score
Files withFORMA THERAPEUTICS INC6GLAXOSMITHKLINE LLC6MURTHI KRISHNA1MURTHI KRISHNA K1SCHOOP ANDREAS1
Top patents by PatentIndex Score
17 records- 0186US8518958B2Pyrido [2,3-D] pyrimidines and their use as kinase inhibitorsMURTHI KRISHNA K·Filed 2007·Granted Aug 27, 2013·9 cites·31 claims
- 0284US9765075B2Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2014·Granted Sep 19, 2017·2 cites·4 claims
- 0376US9834558B2Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2014·Granted Dec 5, 2017·2 cites·2 claims
- 0467US2014163006A1Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase InhibitorsFORMA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 0567US2014163223A1Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase InhibitorsFORMA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 0666US2014163003A1Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase InhibitorsMURTHI KRISHNA·Filed 2013·Application pending·0 cites
- 0765US2018044338A1Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2017·Application pending·0 cites
- 0864US8232283B2Raf inhibitorsSCHOOP ANDREAS·Filed 2011·Granted Jul 31, 2012·2 cites·11 claims
- 0963US2014163005A1Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase InhibitorsFORMA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1063US2014163004A1Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase InhibitorsFORMA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1163US2014163007A1Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase InhibitorsFORMA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1262US10590135B2Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2015·Granted Mar 17, 2020·0 cites·11 claims
- 1361US2014163222A1Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase InhibitorsFORMA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1449US2018186801A1Substituted bicyclic aza-heterocycles and analogues as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2018·Application pending·0 cites
- 1549US2011009381A1Solubilized thiazolopyridinesSIRTIS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1649US2011039847A1Amide derivatives as sirtuin modulatorsSIRTRIS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1735US9957271B2Substituted bicyclic aza-heterocycles and analogues as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2012·Granted May 1, 2018·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →